These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19. Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody. Dahan K; Johannet C; Esteve E; Plaisier E; Debiec H; Ronco P Kidney Int; 2019 Jan; 95(1):233-234. PubMed ID: 30606419 [No Abstract] [Full Text] [Related]
20. Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population. Anjum N; Nabi Z; Alam MA J Ayub Med Coll Abbottabad; 2019; 31(2):265-268. PubMed ID: 31094128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]